In South Africa, Success Against H.I.V. Offers Hopenews2022-01-11T14:59:11+00:00January 11th, 2022|The New York Times|
Family in Nigeria Lost 3 Daughters to Sickle Cell. Can They Save a Fourth?news2021-12-21T12:27:49+00:00December 21st, 2021|The New York Times|
In Africa, Dealing With Vaccine Challenges and the Omicron Variantnews2021-12-03T21:55:34+00:00December 3rd, 2021|The New York Times|
In Africa, Dealing With Vaccine Challenges and the Omicron Variantnews2021-12-03T21:55:34+00:00December 3rd, 2021|The New York Times|
South African Company Nears License to Sell J. & J. Covid Shot Across Africanews2021-11-30T21:07:51+00:00November 30th, 2021|The New York Times|
¿Las vacunas funcionan para la variante ómicron?news2021-11-29T23:50:30+00:00November 29th, 2021|The New York Times|
Will the Vaccines Stop Omicron? Scientists Are Racing to Find Out.news2021-11-28T23:55:10+00:00November 28th, 2021|The New York Times|
Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?news2021-10-17T21:15:06+00:00October 17th, 2021|The New York Times|
Pressure Grows on U.S. Companies to Share Covid Vaccine Technologynews2021-09-22T19:23:27+00:00September 22nd, 2021|The New York Times|
An Experimental H.I.V. Vaccine Fails in Africanews2021-08-31T11:50:11+00:00August 31st, 2021|The New York Times|
